MAOI Medications That Start with P
The only MAOI medication that starts with the letter P is phenelzine (Nardil). 1, 2
Phenelzine: Clinical Information
Mechanism of Action
- Phenelzine is a potent, irreversible inhibitor of monoamine oxidase (MAO) that belongs to the hydrazine derivative class 2
- It works by preventing the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain, thereby increasing their availability 2
Clinical Uses
- Indicated for treatment-resistant depression, particularly melancholic depression 3
- Effective for atypical depression and bipolar depression 4
- Used in the treatment of certain anxiety disorders with high levels of anxiety 1
- Should be considered before electroconvulsive therapy in appropriate cases 3
Dosing
- Available as 15 mg oral tablets 2
- Typically started at lower doses and titrated based on response and tolerability 3
Important Safety Considerations
Contraindications
- Hypersensitivity to phenelzine or its ingredients 2
- Pheochromocytoma, congestive heart failure, severe renal impairment 2
- History of liver disease or abnormal liver function tests 2
- Concomitant use with:
Drug Interactions
- Requires at least 14 days washout period when switching to or from other antidepressants 1
- Requires 5 weeks washout period when switching from fluoxetine 2
- Can cause potentially fatal serotonin syndrome when combined with serotonergic medications 5
- Contraindicated with guanethidine 2
Dietary Restrictions
- Patients must avoid foods high in tyramine to prevent hypertensive crisis 6
- Restricted foods include:
Metabolism
- Metabolized through multiple pathways including acetylation (minor pathway) 7
- Produces metabolites including phenylacetic acid and p-hydroxyphenylacetic acid 7
- May elevate brain GABA levels through metabolic pathways 7
Other MAOIs (Not Starting with P)
For completeness, other MAOIs include:
- Tranylcypromine (irreversible, non-selective MAOI) 3
- Isocarboxazid (irreversible, non-selective MAOI) 3
- Selegiline (MAO-B selective at lower doses) 4
- Moclobemide (reversible MAO-A inhibitor) 4
Clinical Pearls
- Despite recommendations in treatment guidelines, MAOIs like phenelzine are underutilized in clinical practice 4
- Modern food production has reduced tyramine content in many foods, making dietary restrictions more manageable than historically believed 6
- MAOIs should not be considered drugs of last resort but may be appropriate earlier in treatment algorithms for specific depression subtypes 3
- Patients should be educated about recognizing signs of serotonin syndrome and hypertensive crisis 1
- Phenelzine should be discontinued at least 10 days prior to elective surgery requiring general anesthesia 2